In line with demonstrated parallels between BC and GC, IHC studies found a loss of tuberin and hamartin expression, as well as strong immunoreactivity for mTOR in BC (Jozwiak et al., 2004; Grajkowska et al., 2008; Table 2). This evidence concerns the gene MTOR and breast cancer.